ARMP
Price:
$2.015
Market Cap:
$72.91M
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.[Read more]
Industry
Biotechnology
IPO Date
1994-05-20
Stock Exchange
AMEX
Ticker
ARMP
According to Armata Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 89.12%. This represents a change of 265.87% compared to the average of 24.36% of the last 4 quarters.
The mean historical ROE of Armata Pharmaceuticals, Inc. over the last ten years is -6.41%. The current 89.12% ROE has changed -1490.17% with respect to the historical average. Over the past ten years (40 quarters), ARMP's ROE was at its highest in in the March 2015 quarter at 471.16%. The ROE was at its lowest in in the December 2016 quarter at -97.71%.
Average
-6.41%
Median
-111.61%
Minimum
-193.75%
Maximum
672.36%
Discovering the peaks and valleys of Armata Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.67%
Maximum Annual ROE = 672.36%
Minimum Annual Increase = -310.61%
Minimum Annual ROE = -193.75%
Year | ROE | Change |
---|---|---|
2023 | 215.33% | -310.61% |
2022 | -102.24% | 11.83% |
2021 | -91.42% | -24.44% |
2020 | -120.99% | -7.20% |
2019 | -130.37% | -8.77% |
2018 | -142.91% | -13.94% |
2017 | -166.06% | -14.29% |
2016 | -193.75% | 4.67% |
2015 | -4.06% | -100.60% |
2014 | 672.36% | 63.70% |
The current ROE of Armata Pharmaceuticals, Inc. (ARMP) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
7.22%
5-year avg
-45.94%
10-year avg
-6.41%
Armata Pharmaceuticals, Inc.’s ROE is greater than Aravive, Inc. (-433.14%), greater than Aridis Pharmaceuticals, Inc. (-90.29%), greater than Anixa Biosciences, Inc. (-52.41%), greater than BiomX Inc. (-122.65%), greater than Alpine Immune Sciences, Inc. (-14.86%),
Company | ROE | Market cap |
---|---|---|
-433.14% | $2.95M | |
-90.29% | $4.46K | |
-52.41% | $81.54M | |
-122.65% | $10.03M | |
-14.86% | $4.46B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Armata Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Armata Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Armata Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Armata Pharmaceuticals, Inc. (ARMP)?
What is the highest ROE for Armata Pharmaceuticals, Inc. (ARMP)?
What is the 3-year average ROE for Armata Pharmaceuticals, Inc. (ARMP)?
What is the 5-year average ROE for Armata Pharmaceuticals, Inc. (ARMP)?
How does the current ROE for Armata Pharmaceuticals, Inc. (ARMP) compare to its historical average?